
Mastering the Cannabis Harvest: Pro Tips for Cutting, Trimming, Curing, and Storing Your Crop
The harvest season is the most anticipated time for cannabis growers — when months of careful cultivation finally pay off. But cutting down the plants
Over the past decade, the cannabis market in Colorado Springs, Colorado, has experienced dramatic changes, shaped by shifting legal landscapes, economic dynamics, and ongoing debates ahead of the pivotal 2024 election.
Colorado made headlines in 2012 when it became one of the first states in the U.S. to legalize recreational marijuana. However, Colorado Springs opted out of allowing recreational sales, restricting its cannabis market to medical marijuana. This decision was primarily driven by city officials who cited concerns over public safety and federal scrutiny.
Since the legalization, the state’s recreational cannabis market has exploded. While Colorado Springs is not part of this recreational surge, its medical cannabis market has continued to be important the community catering to patients with medical conditions like chronic pain, PTSD, and cancer.
With recreational cannabis still prohibited, Colorado Springs remains home to a robust medical marijuana industry. Several medical dispensaries are serving the needs of patients across the city, and local companies like NuVue Pharma have positioned themselves as leaders in providing high-quality, patient-focused care.
NuVue Pharma, which opened its doors in 2015, has maintained a reputation for prioritizing the health and well-being of medical patients. Their continued commitment includes offering specialized strains and cannabis products tailored to meet their unique needs. They have also invested in education programs to help patients better understand cannabis as a therapeutic option, emphasizing responsible use.
While other businesses have expressed interest in expanding into recreational sales, NuVue Pharma has remained focused on the medical community. As the debate over recreational legalization continues, the company has consistently advocated for patient care and the benefits of medical cannabis, reflecting a long-standing dedication to the local population.
As Colorado Springs prepares for the 2024 election, one of the key issues on the ballot will be whether to permit recreational cannabis sales. Proponents argue that recreational sales could inject millions of dollars into the local economy, much like Denver and other Colorado cities have experienced since the state first allowed adult-use cannabis.
Opponents, however, are concerned about the potential for increased crime, impaired driving, and the broader social consequences of legal recreational cannabis. As it stands, the city council remains divided on the issue, and the election could be a defining moment for the future of Colorado Springs’ cannabis market.
If recreational cannabis is legalized in 2024, it would represent a significant shift in the city’s cannabis policies. Some industry experts predict that Colorado Springs could see a surge in new businesses and job opportunities, as well as a boost in tourism revenue. However, it could also reshape the existing medical cannabis market, forcing companies like NuVue Pharma to adapt to increased competition from recreational retailers.
Despite its absence from the recreational market, Colorado Springs’ medical cannabis industry has remained steady, a testament to the city’s dedicated patient base highlighting the continued demand for medicinal products, even in the face of growing recreational markets in neighboring areas.
NuVue Pharma’s patient-centered approach has allowed it to remain a top player in this market, and expand its product offerings to meet patient needs. With the potential for recreational legalization on the horizon, NuVue’s commitment to medical patients may become even more critical in maintaining a balanced market.
As Colorado Springs navigates this evolving cannabis landscape, the upcoming election, shifting laws, and changing consumer preferences will play key roles in shaping its future. Whether the city opens the door to recreational cannabis or doubles down on its medical-only stance, companies like NuVue Pharma will continue to advocate for patients while adjusting to a rapidly changing industry.
Colorado Springs is at a crossroads. The decisions made in 2024 will not only determine the future of cannabis but will also affect the local economy and community as a whole. The next decade could see an even more dynamic transformation, depending on the outcomes of the city’s regulatory decisions.

The harvest season is the most anticipated time for cannabis growers — when months of careful cultivation finally pay off. But cutting down the plants
Is THCA legal? Explore the fast-evolving U.S. debate over hemp-derived THCA, including industry divide, consumer safety, regulations, economics, and outlook. What is THCA, and why

As cannabis cultivation continues to expand in legal markets, growers are increasingly facing one of nature’s toughest challenges… extreme summer heat. Unlike indoor grow operations

As cannabis becomes increasingly mainstream in the United States, confusion still reigns over the difference between marijuana and hemp, two forms of the same Cannabis

Big changes are blooming at NuVue Pharma — and it’s all good news for your wallet. We’ve heard your feedback and looked closely at how

Despite over half of U.S. states legalizing cannabis for medical or recreational use, federal legalization remains elusive. While public opinion strongly favors reform and the

As the U.S. cannabis industry continues to thrive, driven by expanding state-level legalization and the growth of both medical and adult-use markets, new questions are

Day 1: Clue 1: This game is no trick, to find the Easter Egg you must be quick, get too close today, and I might

In a landmark shift for Colorado Springs, NuVue Pharma is set to commence recreational cannabis sales on April 15, 2025. This development follows a series

Colorado’s cannabis industry is poised for significant changes with the introduction of House Bill HB25-1209, titled “Marijuana Regulation Streamline.” This bill aims to enhance regulatory